117 related articles for article (PubMed ID: 21030693)
21. Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor.
Sherbiny FF; Schiedel AC; Maass A; Müller CE
J Comput Aided Mol Des; 2009 Nov; 23(11):807-28. PubMed ID: 19757091
[TBL] [Abstract][Full Text] [Related]
22. Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptor.
Gao ZG; Balasubramanian R; Kiselev E; Wei Q; Jacobson KA
Biochem Pharmacol; 2014 Aug; 90(3):297-306. PubMed ID: 24853985
[TBL] [Abstract][Full Text] [Related]
23. Adenosine is not a direct GHSR agonist--artificial cross-talk between GHSR and adenosine receptor pathways.
Hermansson NO; Morgan DG; Drmota T; Larsson N
Acta Physiol (Oxf); 2007 May; 190(1):77-86. PubMed ID: 17428235
[TBL] [Abstract][Full Text] [Related]
24. Tritium-labeled agonists as tools for studying adenosine A
Hinz S; Alnouri WM; Pleiss U; Müller CE
Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
[TBL] [Abstract][Full Text] [Related]
25. Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells.
Trincavelli ML; Marroni M; Tuscano D; Ceruti S; Mazzola A; Mitro N; Abbracchio MP; Martini C
J Neurochem; 2004 Dec; 91(5):1180-90. PubMed ID: 15569261
[TBL] [Abstract][Full Text] [Related]
26. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
27. [Advances in the study of A2B adenosine receptor antagonists].
Wei J; Yu WQ; Gao QZ
Yao Xue Xue Bao; 2008 Mar; 43(3):241-6. PubMed ID: 18630258
[TBL] [Abstract][Full Text] [Related]
28. Impact and benefit of A(2B)-adenosine receptor agonists for the respiratory tract: mucociliary clearance, ciliary beat frequency, trachea muscle tonus and cytokine release.
Walaschewski R; Begrow F; Verspohl EJ
J Pharm Pharmacol; 2013 Jan; 65(1):123-32. PubMed ID: 23215695
[TBL] [Abstract][Full Text] [Related]
29. Characterization of [3H]LUF5834: A novel non-ribose high-affinity agonist radioligand for the adenosine A1 receptor.
Lane JR; Klaasse E; Lin J; van Bruchem J; Beukers MW; Ijzerman AP
Biochem Pharmacol; 2010 Oct; 80(8):1180-9. PubMed ID: 20599769
[TBL] [Abstract][Full Text] [Related]
30. Adenosine A2B receptors induce proliferation, invasion and activation of cAMP response element binding protein (CREB) in trophoblast cells.
Darashchonak N; Koepsell B; Bogdanova N; von Versen-Höynck F
BMC Pregnancy Childbirth; 2014 Jan; 14():2. PubMed ID: 24383849
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel quinolinone adenosine A2B antagonists.
McGuinness BF; Ho KK; Stauffer TM; Rokosz LL; Mannava N; Kultgen SG; Saionz K; Klon A; Chen W; Desai H; Rogers WL; Webb M; Yin J; Jiang Y; Li T; Yan H; Jing K; Zhang S; Majumdar KK; Srivastava V; Saha S
Bioorg Med Chem Lett; 2010 Dec; 20(24):7414-20. PubMed ID: 21055932
[TBL] [Abstract][Full Text] [Related]
32. Effects of adenosine A(2A) and A(2B) receptor activation on signaling pathways and cytokine production in human uroepithelial cells.
Säve S; Persson K
Pharmacology; 2010; 86(3):129-37. PubMed ID: 20689344
[TBL] [Abstract][Full Text] [Related]
33. ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor.
Li Q; Ye K; Blad CC; den Dulk H; Brouwer J; Ijzerman AP; Beukers MW
J Pharmacol Exp Ther; 2007 Feb; 320(2):637-45. PubMed ID: 17077318
[TBL] [Abstract][Full Text] [Related]
34. Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation.
Grant MB; Davis MI; Caballero S; Feoktistov I; Biaggioni I; Belardinelli L
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2068-73. PubMed ID: 11481274
[TBL] [Abstract][Full Text] [Related]
35. Corpus cavernosum from men with vasculogenic impotence is partially resistant to adenosine relaxation due to endothelial A(2B) receptor dysfunction.
Faria M; Magalhães-Cardoso T; Lafuente-de-Carvalho JM; Correia-de-Sá P
J Pharmacol Exp Ther; 2006 Oct; 319(1):405-13. PubMed ID: 16837560
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
Varani K; Gessi S; Merighi S; Vincenzi F; Cattabriga E; Benini A; Klotz KN; Baraldi PG; Tabrizi MA; Lennan SM; Leung E; Borea PA
Biochem Pharmacol; 2005 Nov; 70(11):1601-12. PubMed ID: 16219300
[TBL] [Abstract][Full Text] [Related]
37. Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells.
Ryzhov S; Goldstein AE; Biaggioni I; Feoktistov I
Mol Pharmacol; 2006 Aug; 70(2):727-35. PubMed ID: 16707627
[TBL] [Abstract][Full Text] [Related]
38. Structure-affinity relationships of adenosine A2B receptor ligands.
Beukers MW; Meurs I; Ijzerman AP
Med Res Rev; 2006 Sep; 26(5):667-98. PubMed ID: 16847822
[TBL] [Abstract][Full Text] [Related]
39. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
Hinz S; Lacher SK; Seibt BF; Müller CE
J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
[TBL] [Abstract][Full Text] [Related]
40. Loss of constitutive activity is correlated with increased thermostability of the human adenosine A2A receptor.
Bertheleme N; Singh S; Dowell SJ; Hubbard J; Byrne B
Br J Pharmacol; 2013 Jul; 169(5):988-98. PubMed ID: 23489072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
